These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 1312868

  • 1. Antisense inhibition of oncogene expression.
    Neckers L, Whitesell L, Rosolen A, Geselowitz DA.
    Crit Rev Oncog; 1992; 3(1-2):175-231. PubMed ID: 1312868
    [Abstract] [Full Text] [Related]

  • 2. Oncogenes and growth factors in thyroid carcinogenesis.
    Frauman AG, Moses AC.
    Endocrinol Metab Clin North Am; 1990 Sep; 19(3):479-93. PubMed ID: 2175702
    [Abstract] [Full Text] [Related]

  • 3. Antisense inhibition of gene expression: a tool for studying the role of NMYC in the growth and differentiation of neuroectoderm-derived cells.
    Neckers LM, Rosolen A, Whitesell L.
    J Immunother (1991); 1992 Oct; 12(3):162-6. PubMed ID: 1332744
    [Abstract] [Full Text] [Related]

  • 4. c-myc antisense oligodeoxyribonucleotides inhibit proliferation of non-small cell lung cancer.
    Robinson LA, Smith LJ, Fontaine MP, Kay HD, Mountjoy CP, Pirruccello SJ.
    Ann Thorac Surg; 1995 Dec; 60(6):1583-91. PubMed ID: 8787447
    [Abstract] [Full Text] [Related]

  • 5. Non-nuclear oncogenes and the regulation of gene expression in transformed cells.
    Bortner DM, Langer SJ, Ostrowski MC.
    Crit Rev Oncog; 1993 Dec; 4(2):137-60. PubMed ID: 8380545
    [Abstract] [Full Text] [Related]

  • 6. Reduction of erbB2 gene product in mamma carcinoma cell lines by erbB2 mRNA-specific and tyrosine kinase consensus phosphorothioate antisense oligonucleotides.
    Bertram J, Killian M, Brysch W, Schlingensiepen KH, Kneba M.
    Biochem Biophys Res Commun; 1994 Apr 15; 200(1):661-7. PubMed ID: 7909438
    [Abstract] [Full Text] [Related]

  • 7. Modulation of mouse preimplantation development by epidermal growth factor receptor antibodies, antisense RNA, and deoxyoligonucleotides.
    Brice EC, Wu JX, Muraro R, Adamson ED, Wiley LM.
    Dev Genet; 1993 Apr 15; 14(3):174-84. PubMed ID: 8358863
    [Abstract] [Full Text] [Related]

  • 8. [Antisense strategies come of age].
    Yokoyama K.
    Tanpakushitsu Kakusan Koso; 1993 Mar 15; 38(4):753-65. PubMed ID: 8475331
    [No Abstract] [Full Text] [Related]

  • 9. Applications of antisense oligonucleotides in oncology.
    Pierga JY, Magdelenat H.
    Cell Mol Biol (Noisy-le-grand); 1994 May 15; 40(3):237-61. PubMed ID: 7920172
    [Abstract] [Full Text] [Related]

  • 10. Antisense down-regulation of metallothionein induces growth arrest and apoptosis in human breast carcinoma cells.
    Abdel-Mageed A, Agrawal KC.
    Cancer Gene Ther; 1997 May 15; 4(3):199-207. PubMed ID: 9171939
    [Abstract] [Full Text] [Related]

  • 11. Protein kinase A RIalpha antisense inhibition of PC3M prostate cancer cell growth: Bcl-2 hyperphosphorylation, Bax up-regulation, and Bad-hypophosphorylation.
    Cho YS, Kim MK, Tan L, Srivastava R, Agrawal S, Cho-Chung YS.
    Clin Cancer Res; 2002 Feb 15; 8(2):607-14. PubMed ID: 11839683
    [Abstract] [Full Text] [Related]

  • 12. Profiling follicle stimulating hormone-induced gene expression changes in normal and malignant human ovarian surface epithelial cells.
    Ho SM, Lau KM, Mok SC, Syed V.
    Oncogene; 2003 Jul 03; 22(27):4243-56. PubMed ID: 12833147
    [Abstract] [Full Text] [Related]

  • 13. A hitchhiker's guide to antisense and nonantisense biochemical pathways.
    Branch AD.
    Hepatology; 1996 Dec 03; 24(6):1517-29. PubMed ID: 8938189
    [Abstract] [Full Text] [Related]

  • 14. Antisense oligonucleotides as therapeutics for malignant diseases.
    Ho PT, Parkinson DR.
    Semin Oncol; 1997 Apr 03; 24(2):187-202. PubMed ID: 9129689
    [Abstract] [Full Text] [Related]

  • 15. A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1.
    Heikkila R, Schwab G, Wickstrom E, Loke SL, Pluznik DH, Watt R, Neckers LM.
    Nature; 1997 Apr 03; 328(6129):445-9. PubMed ID: 3302722
    [Abstract] [Full Text] [Related]

  • 16. [Inhibition of antisense DNA and its derivative on gastric transformed cell carcinogenicity].
    Yang D, Li T, Xu W.
    Zhonghua Wai Ke Za Zhi; 1995 Jan 03; 33(1):26-8. PubMed ID: 7774440
    [Abstract] [Full Text] [Related]

  • 17. Specific block of androgen receptor activity by antisense oligonucleotides.
    Hamy F, Brondani V, Spoerri R, Rigo S, Stamm C, Klimkait T.
    Prostate Cancer Prostatic Dis; 2003 Jan 03; 6(1):27-33. PubMed ID: 12664061
    [Abstract] [Full Text] [Related]

  • 18. Implication of retinoic acid receptor gamma in squamous differentiation and response to retinoic acid in head and neck SqCC/Y1 squamous carcinoma cells.
    Oridate N, Esumi N, Lotan D, Hing WK, Rochette-Egly C, Chambon P, Lotan R.
    Oncogene; 1996 May 02; 12(9):2019-28. PubMed ID: 8649863
    [Abstract] [Full Text] [Related]

  • 19. The myc family of oncogenes and their presence and importance in small-cell lung carcinoma and other tumour types.
    Prins J, De Vries EG, Mulder NH.
    Anticancer Res; 1993 May 02; 13(5A):1373-85. PubMed ID: 8239508
    [Abstract] [Full Text] [Related]

  • 20. Growth inhibition of human colon carcinoma cells by combinations of anti-epidermal growth factor-related growth factor antisense oligonucleotides.
    Normanno N, Bianco C, Damiano V, de Angelis E, Selvam MP, Grassi M, Magliulo G, Tortora G, Bianco AR, Mendelsohn J, Salomon DS, Ciardiello F.
    Clin Cancer Res; 1996 Mar 02; 2(3):601-9. PubMed ID: 9816209
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.